These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35647859)

  • 1. COVID-19 susceptibility and clinical outcomes in autoimmune inflammatory rheumatic diseases (AIRDs): a systematic review and meta-analysis.
    Shin JI; Kim SE; Lee MH; Kim MS; Lee SW; Park S; Shin YH; Yang JW; Song JM; Moon SY; Kim SY; Park Y; Suh DI; Yang JM; Cho SH; Jin HY; Hong SH; Won HH; Kronbichler A; Koyanagi A; Jacob L; Hwang J; Tizaoui K; Lee KH; Kim JH; Yon DK; Smith L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3760-3770. PubMed ID: 35647859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysis.
    Al-Haideri M; Mohammad TAM; Darvishzadehdeldari S; Karbasi Z; Alimohammadi M; Faramarzi F; Khorasani S; Rasouli A; Tahmasebi S; Darvishi M; Akhavan-Sigari R
    Int J Rheum Dis; 2023 Jul; 26(7):1227-1234. PubMed ID: 37309305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
    Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
    Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 outcomes in patients with and without autoimmune rheumatic diseases: A multicenter comparative study.
    Abdulnaby NK; Gamal SM; Alkemary A; Abdo M; Sabry IM; Belita MI; Mohamed SS
    Int J Rheum Dis; 2023 May; 26(5):870-877. PubMed ID: 36929695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study.
    Kim YK; Kim JY; Jung JI; Park JK; Lee EY; Lee EB; Park JW
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37973535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case-Control Study from Astana, Kazakhstan.
    Rutskaya-Moroshan K; Abisheva S; Abisheva A; Amangeldiyeva Z; Vinnik T; Batyrkhan T
    Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336418
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs.
    Nakafero G; Grainge MJ; Myles PR; Mallen CD; Zhang W; Doherty M; Nguyen-Van-Tam JS; Abhishek A
    Rheumatology (Oxford); 2020 Dec; 59(12):3666-3675. PubMed ID: 32160295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases.
    Chevalier K; Genin M; Jean TP; Avouac J; Flipo RM; Georgin-Lavialle S; El Mahou S; Pertuiset E; Pham T; Servettaz A; Marotte H; Domont F; Chazerain P; Devaux M; Mekinian A; Sellam J; Fautrel B; Rouzaud D; Ebstein E; Costedoat-Chalumeau N; Richez C; Hachulla E; Mariette X; Seror R
    Front Med (Lausanne); 2023; 10():1152587. PubMed ID: 37035330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study.
    Wang W; Wang YH; Huang CH; Hsieh TH; Ibarburu GH; Wei JC
    BMC Med; 2024 Mar; 22(1):117. PubMed ID: 38481216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers With Autoimmune or Inflammatory Rheumatic Disease: A Retrospective Cohort Analysis From the National COVID Cohort Collaborative.
    Anzalone AJ; Jackson LE; Singh N; Danila MI; Reisher E; Patel RC; Singh JA;
    Arthritis Care Res (Hoboken); 2024 Aug; ():. PubMed ID: 39158165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Infection In Patients With Autoimmune Rheumatic Diseases: Patient's Perspective And Descriptive Analysis From A Lower-Middle-Income Country.
    Riaz M; Ishaq S; ; Jibril H; Zafar Mahmood SB; Riaz M
    J Pak Med Assoc; 2023 Oct; 73(10):2059-2061. PubMed ID: 37876070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
    Shenoy P; Ahmed S; Shanoj KC; Shenoy V; Damodaran D; Menon AR; Alias B; SanjoSaijan ; Devakumar D; Babu ASS
    Clin Rheumatol; 2021 Nov; 40(11):4665-4670. PubMed ID: 34155573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.
    Akiyama S; Hamdeh S; Micic D; Sakuraba A
    Ann Rheum Dis; 2021 Mar; 80(3):384-391. PubMed ID: 33051220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
    Pang R; Zhao J; Gan Z; Hu Z; Xue X; Wu Y; Qiao Q; Zhong A; Xia X; Liao H; Wang Z; Zhang L
    Aging (Albany NY); 2020 Dec; 12(23):23427-23435. PubMed ID: 33289698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and disease burden of autoimmune inflammatory rheumatic diseases after non-pharmaceutical interventions in the COVID-19 era: A nationwide observational study in Korea.
    Shin JH; Pyo JY; Han M; Lee M; Lim SM; Baek JY; Lee JY; Kang JM; Jung I; Ahn JG
    Int J Rheum Dis; 2024 Apr; 27(4):e15144. PubMed ID: 38590055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Rheumatic Diseases and Outcomes Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Ang SP; Chia JE; Misra K; Krittanawong C; Iglesias J; Gewirtz D; Mukherjee D
    Angiology; 2024 May; ():33197241255167. PubMed ID: 38771845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic.
    Dey D; Katso B; Issaka S; Adjei P
    Intern Med J; 2024 Aug; 54(8):1376-1383. PubMed ID: 38816941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature.
    Akkuzu G; Bes C; Özgür DS; Karaalioğlu B; Mutlu MY; Yıldırım F; Atagündüz P; Gündüz A; Soy M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2143-2151. PubMed ID: 36930514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of autoimmune rheumatic disease-related organizing pneumonia.
    Dong X; Zheng Y; Wang L; Chen WH; Zhang YG; Fu Q
    Clin Rheumatol; 2018 Apr; 37(4):1027-1035. PubMed ID: 28748510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.